TD Asset Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

TD Asset Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-402,081	Closed	-$6.82M	–	1449
2014 Q4	$6.82M	Sell	402,081 -141,400	-26%	-$1.99M	0.01%	589
2014 Q3	$6.48M	Buy	543,481 +40,600	+8%	+$277K	0.01%	572
2014 Q2	$2.84M	Sell	502,881 -29,500	-6%	-$136K	﹤0.01%	774
2014 Q1	$1.95M	Buy	532,381 +32,900	+7%	+$125K	﹤0.01%	827
2013 Q4	$1.68M	Buy	499,481 +62,381	+14%	+$258K	﹤0.01%	831
2013 Q3	$1.85M	Buy	437,100 +41,300	+10%	+$196K	﹤0.01%	806
2013 Q2	$1.82M	Buy	+395,800	New	+$1.36M	﹤0.01%	780

TD Asset Management's AVNR Position: Q1 2015 in Review

TD Asset Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 402,081 shares — an estimated $6.82M sold.

TD Asset Management first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $6.82M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

TD Asset Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
TD Asset Management sold 402,081 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $6.82M.
TD Asset Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
TD Asset Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $6.82M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on TD Asset Management's 13F filing for Q1 2015, filed 28 Apr 2015.